Malignant otitis externa in Australian Aboriginal patients: A 9-year retrospective analysis from the Northern Territory.


Journal

The Australian journal of rural health
ISSN: 1440-1584
Titre abrégé: Aust J Rural Health
Pays: Australia
ID NLM: 9305903

Informations de publication

Date de publication:
Feb 2019
Historique:
accepted: 02 08 2018
pubmed: 31 1 2019
medline: 14 6 2019
entrez: 31 1 2019
Statut: ppublish

Résumé

In the Australian Aboriginal population, type 2 diabetes occurs at a much higher prevalence, with a much younger age of onset of the disease and its complications. Despite the clear association with malignant otitis externa, no previous studies have examined malignant otitis externa in this population. This study explores the pattern of malignant otitis externa amongst Australian Aboriginal patients in the Northern Territory. Retrospective case series. Otolaryngology unit in a tertiary referral hospital in Northern Territory, Australia. Patients admitted with malignant otitis externa between January 2007 and October 2016 were identified by reviewing case notes. Patients diagnosed with malignant otitis externa based on results from clinical, microbiological and radiological criteria were included. Complications rates, duration of hospital stay and parenteral antibiotics, age of onset and causative organisms. Nine patients were included. Six were Australian Aboriginal - all from regional centres. The most common causative organism was Pseudomonas aeruginosa. There was a higher-than-expected occurrence of fungal malignant otitis externa (33% of Australian Aboriginal patients), who tended to be younger at diagnosis, had longer hospital stays and had a higher disease-specific mortality. Over half of the patients did not receive follow-up gallium bone scans to monitor disease resolution, reflecting the limitations of rural health care. Malignant otitis externa in the Australian Aboriginal population is a challenging disease with high complication and mortality rates. Their rural and remote distribution is a significant barrier to specialist investigation and care. Providing effective care for this disease requires improved access to high-quality primary health care and tertiary specialist services.

Identifiants

pubmed: 30698313
doi: 10.1111/ajr.12468
doi:

Types de publication

Journal Article

Langues

eng

Pagination

78-82

Informations de copyright

© 2019 National Rural Health Alliance Ltd.

Auteurs

Tze Ling Loh (TL)

Royal Darwin Hospital, Tiwi, Northern Territory, Australia.

Laura Renger (L)

Royal North Shore Hospital, St Leonards, New South Wales, Australia.

Sergios Latis (S)

Otolaryngology Head and Neck Surgery, Royal Darwin Hospital, Tiwi, Northern Territory, Australia.

Hemi Patel (H)

Otolaryngology Head and Neck Surgery, Royal Darwin Hospital, Tiwi, Northern Territory, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH